Case Report

Cutaneous tuberculosis: An infrequent manifestation of a common pathogen in South Africa

Jennifer K. van Heerden, Alistair G.B. Broadhurst, Ruan S. de Jager, Wesley du Plessis, Nabilah Ebrahim, Ayanda T. Mnguni, Denzil Schietekat, Graeme Meintjes

Received: 21 Mar. 2023; Accepted: 08 May 2023; Published: 13 June 2023

Copyright: © 2023. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Cutaneous tuberculosis is an infrequent form of extra-pulmonary tuberculosis, even in high-prevalence settings. We present the case of a patient living with advanced HIV who developed extensive cutaneous tuberculosis. The polymorphic skin lesions were the most striking clinical manifestation of underlying disseminated tuberculosis.

Contribution: This case report highlights an unusual presentation of tuberculosis. Cutaneous tuberculosis has a wide spectrum of clinical presentations and may be under-recognised by clinicians. We recommend early biopsy for microbiological diagnosis.

Keywords: cutaneous tuberculosis; human immunodeficiency virus; HIV; tuberculosis; TB; South Africa.

Background

Tuberculosis (TB) remains a significant contributor to the global burden of disease and an estimated 10.6 million people fell ill with TB in 2021 (95% uncertainty interval: 9.9–11 million).¹ Despite the high incidence of TB, often occurring in the setting of human immunodeficiency virus (HIV) co-infection, cutaneous TB is infrequent, comprising less than 2% of all extra-pulmonary forms of TB.^2,3,4 As an infrequent and possibly under-recognised presentation of TB, there is a paucity of clinical and microbiological data on cutaneous TB in South Africa.

Cutaneous TB predominantly refers to skin disease caused by Mycobacterium tuberculosis (MTB); although, rarely, it can be caused by Mycobacterium bovis or develop from the attenuated form of M. bovis contained in the bacillus Calmette-Guerin (BCG) vaccine.⁴ Additionally, cutaneous hypersensitivity reactions to antigen components of MTB are often included as forms of cutaneous TB.⁵ Cutaneous TB may have a wide variety of clinical presentations each with distinct morphologies. This heterogeneity contributes to diagnostic difficulty, delayed diagnoses and ultimately a delay in initiation of effective treatment.

In light of this, we present a patient with an unusual presentation of cutaneous TB and highlight in the discussion the varied presentation of cutaneous TB, to contribute to the literature on this condition in South Africa. We emphasise the need for prompt recognition with early biopsy for microbiological diagnosis and determination of drug sensitivities to guide therapy.

Case presentation

A 38-year-old woman with advanced HIV disease (antiretroviral treatment experienced with treatment interruption) presented to Khayelitsha District Hospital with multiple cutaneous abscesses and associated constitutional symptoms of loss of appetite, loss of weight and night sweats. She reported a 3-month history of subcutaneous swellings with overlying hyperpigmentation affecting the arms, legs and buttocks, which subsequently formed spontaneous sinuses with drainage of purulent discharge.

The patient had a history of three previous episodes of drug-sensitive TB and had completed anti-TB treatment on all occasions (Table 1). She had recently been admitted to the surgical department where she was diagnosed with lower limb cellulitis complicated by soft tissue collections. During that admission, an incision and drainage procedure was performed, and the patient received an oral course of amoxicillin and clavulanic acid. Routine microscopy, culture and sensitivity of the pus did not identify any bacterial pathogen; however, a specific mycobacterial culture was not requested.

On admission to the internal medicine department, the patient had a tachycardia and a documented fever. She was cachectic with pallor and generalised lymphadenopathy. She had multiple skin lesions with a widespread distribution, affecting predominantly the lower limbs, perianal area, hands and face. The lower limb and perianal lesions involved subcutaneous collections with overlying hyperpigmented patches and central fluctuance. Certain of these collections had ulcerated with draining sinuses (Figure 1). Her facial lesions were hyperpigmented papules and plaques predominantly affecting the nasal area and associated with crusting suggestive of lupus vulgaris (Figure 2). Initial blood results showed acute kidney impairment, normocytic anaemia and an elevated C-reactive protein (Table 2).

FIGURE 1: Lower limb subcutaneous collection with draining sinuses.

FIGURE 2: Hyperpigmented papules and plaques affecting the perioral and nasal area.

Differential diagnosis

The differential diagnosis for this patient’s initial presentation was relatively broad, with infectious causes being the most important considerations.

Firstly, Staphylococcus aureus (including methicillin-resistant S. aureus) and Streptococcus pyogenes are the two most significant bacterial pathogens causing cutaneous abscesses.⁶ The negative bacterial cultures from the surgical drainage procedure and the chronic course of this presentation made us consider these causes unlikely. Secondly, although far less common, actinomycosis should be considered in this patient with significantly compromised immunity. This sub-acute or chronic suppurative, granulomatous infection caused by Actinomyces spp. may cause purulent, mass-like lesions with draining sinuses, similar to those described here.⁷

Mycobacterial opportunistic diseases such as MTB and nontuberculous mycobacteria are important aetiologies to consider, as well as other acid-fast bacilli, such as Nocardia spp., that may mimic TB presentations.⁸ Cutaneous syphilitic gumma, as a manifestation of tertiary syphilis, may also be considered.⁴

Deep fungal infections may have chronic cutaneous manifestations similar to this case.^9,10 The subcutaneous mycoses such as sporotrichosis and mycetoma, as well as the systemic mycoses such as blastomycosis, cryptococcosis and histoplasmosis were all considered in this patient with profound immune compromise.^4,9

Case management

Investigations

Laboratory findings are listed in Table 2. Blood cultures showed no growth after 5 days and serum cryptococcal antigen and rapid plasma reagin were non-reactive. The patient developed delirium on day three of admission, necessitating a lumbar puncture for cerebrospinal fluid (CSF) analysis that revealed a lymphocytic pleocytosis and an elevated protein that was suggestive of TB meningitis despite a negative CSF GeneXpert.

A pus aspirate from the largest skin lesion was performed, from which acid-fast bacilli were observed on microscopy and MTB complex was detected by real-time polymerase chain reaction (RT-PCR) testing, with the MTB determined as sensitive to rifampicin (Xpert^® MTB/Rif Ultra, Becton Dickinson, United States). Prompt consultation with dermatology was sought for a skin biopsy, where MTB was detected by Xpert^® MTB/Rif Ultra on the tissue sample and histopathology showed organising inflammation (Table 3).

Concurrently to the investigation of the skin lesions, laboratory evidence for disseminated TB was sought. A urinary lipoarabinomannan test was positive and a gastric aspirate demonstrated MTB complex, detected by Xpert^® MTB/Rif Ultra, with MTB complex isolated by mycobacterial culture. Radiological investigations provided further evidence supporting a diagnosis of disseminated TB with upper lobe cavitation seen on chest radiography and multiple hypoechoic splenic lesions detected by abdominal ultrasound (Table 4).

Outcome and follow-up

The patient was started on anti-TB therapy with rifampicin, isoniazid, ethambutol and pyrazinamide. Corticosteroids were added to the treatment regimen after TB meningitis was diagnosed. The patient was transferred to a designated TB hospital where she continued anti-TB therapy and antiretroviral treatment was subsequently initiated. She had a good clinical response to treatment with marked improvement in all skin lesions and no neurological impairment on discharge from this facility. The discharge plan was to complete a total duration of 9 months of anti-TB therapy on an outpatient basis.

Discussion

This case report demonstrates that multiple cutaneous abscesses in an immunosuppressed individual should alert the treating clinician to consider cutaneous TB. However, this is only one possible form of cutaneous TB as there are many varied presentations of the condition, depending on multiple factors such as the route of transmission, the host’s cellular immunity, the proximity to lymph nodes and the microbial virulence.¹¹

The spectrum of cutaneous TB ranges from inflammatory papules and verrucous plaques to chronic ulcerative lesions and cold abscesses.^3,4,11 Cutaneous TB can be broadly categorised according to the mechanism of infection (outlined in Table 5) as this determines the type of lesion.¹² For example, spread from an exogenous source (direct inoculation of bacilli) may cause a tuberculous chancre, whereas spread from an endogenous source may cause other manifestations of cutaneous TB, such as lupus vulgaris. Although the mode of infection may not be clear in all cases, in our patient the spread was almost certainly endogenous via haematogenous dissemination.^4,11

In another classification analogous to the Ridley and Jopling classification for leprosy, the bacterial load can be used to classify cutaneous TB. Multibacillary forms include scrofuloderma, acute miliary tuberculosis and tuberculous gumma, whereas paucibacillary forms include verrucous tuberculosis and tuberculids.^4,5 This classification also provides insight into the immune pathogenesis of cutaneous TB and its relationship to the patient’s cellular immunity to MTB. For example, tuberculids, a paucibacillary form of cutaneous TB, develop as immunological reactions to antigenic components of mycobacteria and usually occur in patients with a good cellular immunity.¹³ Conversely, in our patient who was severely immunocompromised, the lesions were multibacillary, as evidenced by the positive stain for acid-fast bacilli on the pus aspirated.

The multiple subcutaneous tuberculous abscesses in our patient are analogous to ‘tuberculous gumma’, lesions that characteristically affect individuals during periods of decreased cellular immunity, such as advanced HIV.¹¹ Tuberculous gumma typically affects the trunk and lower extremities and may ulcerate and drain caseous material or pus.¹¹ Another manifestation of cutaneous TB with a similar mechanism of spread and affecting a similar patient population is acute miliary cutaneous TB, where lesions appear as generalised papules, vesicles or pustules.^12,14 These two manifestations of cutaneous TB are important to recognise as they may be associated with poor outcomes if therapy is delayed given underlying disseminated TB.

The pattern of cutaneous facial involvement observed in our case was suggestive of lupus vulgaris; however, other forms of cutaneous TB may present similarly and were considered as possible alternative diagnoses. For example, TB cutis orificialis may cause ulcerative cutaneous and mucosal lesions in periorificial areas and usually occurs in individuals with TB at other sites as well as those with impaired immunity.^3,4 Additionally, non-mycobacterial cutaneous manifestations of systemic diseases such as syphilis and systemic mycoses formed an important part of the differential diagnosis of the facial lesions in this case.^3,4,5

It is imperative to obtain early tissue samples in patients with suspected cutaneous TB. Culture remains the gold standard for making a microbiological diagnosis of TB; however, nucleic acid amplification testing (such as by the Xpert^® MTB/Rif Ultra test) has been shown to be a sensitive and specific diagnostic test on pus aspirates as well as tissue homogenate.^2,15,16 Xpert^® MTB/Rif Ultra performed on both the pus aspirate and tissue were positive for MTB in our patient. This test has the benefit of rapid turnaround time with rifampicin sensitivity testing, allowing for early treatment. Histopathology of cutaneous TB shows inflammation and, classically, caseating granulomas.⁴ The absence of caseating granulomas in our patient is unusual; however, it is reported in approximately 10% of cases of cutaneous TB and likely related to profound immunosuppression in our patient.¹⁷

In our patient, the subcutaneous abscesses present during the previous admission that did not resolve with incision, drainage and antibiotics were almost certainly a missed manifestation of cutaneous TB as no TB tests were requested at the time. This phenomenon is described in other case reports, where patients with cutaneous TB often receive multiple courses of antibiotics prior to diagnosis.² Although S. aureus was cultured on pus aspirate in our case, it was not considered causative but rather a secondary infection that entered via a draining sinus.

Treatment of cutaneous TB does not differ from other forms of TB and our patient showed a good response to effective combination therapy. Concurrent TB at other sites should be fully investigated as this may guide the duration of treatment and the need for adjuvant glucocorticoids.

Acknowledgements

The authors wish to thank the dedicated staff at Khayelitsha District Hospital, Tygerberg Hospital and D.P Marais Hospital for their role in the care of the patient described in this case report.

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

J.K.v.H. wrote the case report. G.M., A.G.B.B., A.T.M., W.d.P., D.S., N.E. and R.S.d.J. critically reviewed the manuscript. All authors approved the final version.

Ethical clearance to conduct this study was obtained from the Stellenbosch University Health Research Ethics Committee (No. C22/10/031).

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

The authors confirm that the data supporting the findings of this study are available within the article.

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any affiliated agency of the authors.

References